Stockreport

Can Glaukos' (GKOS) Latest FDA Approval Reinforce Its Corneal Therapy Leadership? [Yahoo! Finance]

Glaukos Corporation  (GKOS) 
Last glaukos corporation earnings: 2/27 04:15 pm Check Earnings Report
PDF keratoconus, following positive results from two Phase 3 clinical trials involving more than 400 patients. This approval expands Glaukos' corneal portfolio and builds [Read more]